Editorial
Copyright ©The Author(s) 2015.
World J Nephrol. Nov 6, 2015; 4(5): 487-491
Published online Nov 6, 2015. doi: 10.5527/wjn.v4.i5.487
Figure 1
Figure 1 Graft injury and clinical presentation after development of de novo donor specific antibody. The pathologic injury of ABMR starts from microvascular inflammation, including peritubular capillaritis, C4d staining in allograft, and glomerulitis, to interstitial fibrosis/tubular atrophy (IF/TA) and transplant glomerulopathy (TG). GFR: Glomerular filtration rate; ABMR: Antibody mediated rejection; DSA: Donor specific antibody.